Wert202020212022202320242025TTMMittelzufluss aus Investitionstätigkeit-554 M-1.07 B-591 M-231 M-178 M-55 M-358 MZahlungsströme aus der Finanzierungstätigkeit-766 M-51 M1 B-1.21 B-570 M-744 M-800 MFreier Cashflow1.08 B545 M392 M478 M837 M931 M974 M
Illumina, Inc. - Common Stock
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.